Tenocyte Culture Assays: How Researchers Model Tendon Cell Growth

Tendon is slow, dense and hard to watch in a living animal. So researchers often start with cells in a dish. This article is for research use only, and it explains how tenocyte culture assays work: how tendon cells are grown, what each readout actually measures, and why a result in one dish may not carry over to another. If you're researching peptides studied in tendon models, knowing the assay is the fastest way to read the paper critically.

Starting a tenocyte culture

In short: most tenocyte work begins either with small pieces of tendon or with enzymes that free the cells from it.

Explants and enzymatic digestion

In one rat study, researchers isolated tendon fibroblasts from the Achilles tendons of male Sprague-Dawley rats. They minced the tendon into pieces of roughly 1.5 to 2.0 mm³, placed them in six-well plates with DMEM and 10% fetal bovine serum, and let cells migrate out at 37 °C in 5% CO₂. A different group working with neonatal mouse tendon used collagenase digestion for four hours, then expanded the cells in high-glucose DMEM with 10% serum.

Both routes give elongated, fibroblast-like cells. Papers call them tenocytes or tendon fibroblasts, and the terms are often used loosely.

Passage, media and donors

Primary cells change as they are split again and again, so labs fix a narrow passage window. The rat study used passages 2 to 4, and a human tenocyte study used passages 3 to 5. That human work used cells from three commercial donors aged 61 to 81, grown in a 10% serum growth medium and tested in a 2.5% serum assay medium. Lower serum in the assay step keeps background growth down. A treatment effect is easier to see that way.

Choosing a cell source

In short: the cell source quietly shapes every result.

Rat, mouse and human tenocytes are not interchangeable. Donor age, tendon location, species and passage all change how cells behave. Commercial human cells save time but come from a handful of donors; primary rodent cells are fresh but come from a different species than the one most readers care about. The same logic applies in other cell models, such as the SH-SY5Y cell assay designs used for neuropeptides: the line you pick limits what you can say afterward.

Proliferation readouts

In short: three common tools answer "are there more cells?", and none answers it perfectly.

MTT and AlamarBlue

MTT assays measure how much of a yellow dye cells convert to purple formazan, read by absorbance at 570 nm. The rat fibroblast study seeded about 1 × 10⁵ cells per well. AlamarBlue works on a similar principle with a fluorescent or colorimetric dye. In the human tenocyte study, 3,300 cells per well in 48-well plates were followed for 14 days, with fresh medium on days 1, 4, 7 and 10, and a standard curve turned absorbance into an estimated cell number.

The catch: both assays read metabolic activity. MTT is a proxy for viable cells, not a direct count. If a treatment changes cell metabolism without changing cell number, the readout can mislead.

EdU incorporation

EdU is a modified nucleoside that cells take up while copying DNA. A short pulse, then a fluorescent detection step, labels the cells that were dividing. In the neonatal mouse study, cells received EdU for 30 minutes before harvest. It's more direct than MTT, but it only captures the window of the pulse.

Anything added to the culture medium can interfere too. If you're comparing peptide preparations, see why TFA salts can skew cell proliferation assays.

Migration readouts

In short: migration assays ask whether cells move, either across a gap or through a membrane.

The scratch assay

Cells grow to a monolayer, a pipette tip drags a gap through the middle, and a camera tracks closure. In the mouse tenocyte work, cells were serum-starved for 24 hours first, then placed in plain DMEM, DMEM with 10% serum, or serum plus 10 ng/mL TGFB1. Images were taken every 4 hours for 12 hours. Cells in plain medium did not migrate at all, which is why the controls matter as much as the treatment.

The transwell (Boyden chamber) assay

Here cells sit in an upper insert and the test condition sits below, separated by a porous membrane. The human tenocyte study loaded 5,000 cells per insert on 8 µm-pore membranes for 24 hours, stained migrated cells with crystal violet, and counted five fields per well in ImageJ. A low-serum medium served as the negative control and growth medium as the positive control. Transwells measure movement toward something; scratch assays measure a mix of movement and spreading into open space.

Separating migration from proliferation

In short: a closing gap does not tell you why it closed.

A gap can shrink because cells move in, because they divide, or both. The mouse study paired the scratch assay with EdU labeling. TGFB1 sped up closure, with differences visible by 4 hours and near-complete closure by 8 hours, yet EdU incorporation was about 2.9% in plain medium, 3.5% with serum and 3.3% with serum plus TGFB1 (p = 0.8). The authors read that as movement, not division.

The authors flagged a caveat too: EdU was measured at a single time point (8 hours) while closure was followed for 12, so the separation is indirect. Time-lapse tracking of single cells, or a division blocker, would be stronger evidence.

A research example: BPC 157 in tendon cultures

In short: one lab's rat-cell work shows how several assays are combined, and why their combined answer is nuanced.

A 2011 study in the Journal of Applied Physiology tested BPC 157 in rat Achilles tendon cells. The abstract reports that the peptide significantly accelerated the outgrowth of tendon explants, increased fibroblast migration in a concentration-dependent way in a transwell filter assay, and promoted cell spreading. It did not directly change proliferation by MTT, but it improved survival of cells exposed to hydrogen peroxide. Staining showed more F-actin, and western blots showed higher phosphorylation of FAK and paxillin with no change in total protein levels. The authors concluded the FAK-paxillin pathway was likely involved.

A follow-up from the same group found that BPC 157 raised growth hormone receptor mRNA and protein in cultured tendon fibroblasts, reaching up to about sevenfold by day three at 0.5 µg/mL. MTT-measured viable cell numbers rose only when growth hormone was added after pretreatment. So the proliferation story depends on which experiment you read. The same group's earlier paper found no direct proliferation effect.

BPC-157 is also a research-grade compound name that is not equivalent to any approved pharmaceutical product. Findings like these are cell-culture observations, and the broader question of reproducibility is covered in our piece on why independent replication matters.

Limits of in vitro tendon models

In short: a dish shows what cells do in a dish.

• Single species and cell type. The rat growth hormone receptor paper acknowledges that its culture cannot mimic the real tendon environment, which includes other cells and a stiff matrix.
• Small, repeated samples. That study used three experiments, each with cells from a different rat.
• Proxy readouts. MTT and AlamarBlue are metabolic stand-ins for cell number.
• Causality is not settled. Linking a peptide to a receptor or signaling change does not prove that the change drives the cell behavior. That would need knockdown or inhibitor experiments.
• Funding and donor context. The human tenocyte study used three older male donors and was run by employees of the company that makes the product tested.

The takeaway

Every tenocyte assay answers a narrow question. Culture method, passage, serum level, control media and readout all decide what the result can say. When you read a tendon-cell paper, check which cells were used, what the negative control did, and whether movement and growth were measured separately. Then treat the result as a hypothesis for the next experiment, not a conclusion about tendon in a living body.

Frequently Asked Questions

What is a tenocyte?

A tenocyte is the main resident cell of tendon, an elongated fibroblast-like cell that builds and maintains the collagen-rich matrix. Labs culture them from tendon explants or from enzymatic digestion of tendon tissue.

Does MTT count cells?

No. MTT and AlamarBlue read metabolic activity, which is used as a proxy for viable cell number. Direct counts or DNA-binding dyes can give a different picture.

Why use both a scratch assay and EdU?

A scratch assay shows gap closure, which can come from movement or from cell division. EdU labeling tests whether division is enough to explain the closure.

Do rat tenocyte results apply to human cells?

Not automatically. Species, donor age and passage all affect results, so findings from one cell source are hypotheses for another.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.